ORGO

Black Swan Sale

50% Off Elite

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

Peers: JNJ MDT SYK BSX DHR ZBH EW ISRG HOLX XRAY

| Held by: IWM VTI VXF IWO SCHA DFAS DFAC VTWO FESM IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.10	Insider Own	52.89%	Shs Outstand	126.91M	Perf Week	1.17%
Market Cap	657.40M	Forward P/E	29.52	EPS next Y	0.18	Insider Trans	0.43%	Shs Float	58.83M	Perf Month	24.22%
Enterprise Value	764.69M	PEG	-	EPS next Q	0.22	Inst Own	54.13%	Short Float	18.50%	Perf Quarter	0.58%
Income	-11.60M	P/S	1.41	EPS this Y	1617.00%	Inst Trans	-20.64%	Short Ratio	7.27	Perf Half Y	89.05%
Sales	465.22M	P/B	2.58	EPS next Y	15.66%	ROA	0.21%	Short Interest	10.88M	Perf YTD	61.87%
Book/sh	2.01	P/C	10.21	EPS next 5Y	-	ROE	0.30%	52W High	7.08 -26.81%	Perf Year	28.22%
Cash/sh	0.51	P/FCF	-	EPS past 3/5Y	-79.03% -	ROIC	-2.78%	52W Low	2.61 98.46%	Perf 3Y	91.14%
Dividend Est.	-	EV/EBITDA	27.16	Sales past 3/5Y	1.04% 13.06%	Gross Margin	69.33%	Volatility	7.60% 8.71%	Perf 5Y	1.97%
Dividend TTM	-	EV/Sales	1.64	EPS Y/Y TTM	-67.56%	Oper. Margin	0.39%	ATR (14)	0.43	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.88	Sales Y/Y TTM	2.24%	Profit Margin	-2.49%	RSI (14)	50.71	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.32	EPS Q/Q	20.52%	SMA20	-2.33%	Beta	1.46	Target Price	8.50
Payout	0.00%	Debt/Eq	0.11	Sales Q/Q	30.98%	SMA50	11.11%	Rel Volume	0.29	Prev Close	5.42
Employees	869	LT Debt/Eq	0.08	Earnings	Nov 06 AMC	SMA200	18.76%	Avg Volume	1.50M	Price	5.18
IPO	Jan 05, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	88.77% 12.48%	Trades		Volume	434,546	Change	-4.43%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-28-24	Initiated	Lake Street	Buy	$5
Feb-07-24	Initiated	Cantor Fitzgerald	Overweight	$5
Jun-15-23	Initiated	Morgan Stanley	Equal-Weight	$5
May-24-23	Upgrade	BTIG Research	Neutral → Buy	$10
Nov-10-22	Downgrade	BTIG Research	Buy → Neutral
Aug-10-22	Downgrade	Oppenheimer	Outperform → Perform
Jan-10-20	Initiated	SVB Leerink	Outperform	$9
Aug-26-19	Resumed	Credit Suisse	Outperform	$9 → $10
May-02-19	Initiated	Credit Suisse	Outperform	$9
Apr-17-19	Initiated	Oppenheimer	Outperform	$11
Apr-11-19	Initiated	SunTrust	Buy	$11

Show Previous Ratings

Nov-07-25 12:10AM	Organogenesis Holdings Inc (ORGO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) +44.73%
Nov-06-25 04:26PM	Organogenesis: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Organogenesis Holdings Inc. Reports Third Quarter 2025 Financial Results, Posts Record Revenue and Raises 2025 Guidance (GlobeNewswire)
Nov-03-25 01:10PM	Organogenesis Applauds CMS's Significant Step In Payment Reform (GlobeNewswire) -5.88%
Oct-31-25 04:05PM	Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
04:05PM	Loading…
Oct-01-25 04:05PM	Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025 (GlobeNewswire)
Sep-26-25 11:24AM	Why Is Organogenesis Stock Trading Lower Friday? (Benzinga) -12.39%
Sep-25-25 04:50PM	Organogenesis Provides Update on Second Phase 3 ReNu Study (GlobeNewswire)
Aug-27-25 04:05PM	Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September (GlobeNewswire) +5.79%
Aug-08-25 03:41AM	Organogenesis Holdings Inc (ORGO) Q2 2025 Earnings Call Highlights: Navigating Market ... (GuruFocus.com)
Aug-07-25 05:49PM	Organogenesis: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-22-25 04:05PM	Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025 (GlobeNewswire) +5.70%
Jul-15-25 09:00AM	Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation (GlobeNewswire) -10.24%
Jul-14-25 05:22PM	MiMedx and Organogenesis stocks tumble after CMS proposal to slash spending (Investing.com)
03:51AM	Loading…
May-09-25 03:51AM	Organogenesis Holdings Inc (ORGO) Q1 2025 Earnings Call Highlights: Navigating Market ... (GuruFocus.com) -42.70%
May-08-25 06:05PM	Organogenesis (ORGO) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:57PM	Organogenesis: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 10:41AM	Organogenesis Holdings Inc (ORGO) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Apr-11-25 04:05PM	Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness (GlobeNewswire) +13.60%
Apr-07-25 04:05PM	Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025 (GlobeNewswire)
Feb-28-25 11:14AM	Q4 2024 Organogenesis Holdings Inc Earnings Call (Thomson Reuters StreetEvents) +102.28%
02:42AM	Organogenesis Holdings Inc (ORGO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
12:45AM	Organogenesis (ORGO) Q4 2024 Earnings Call Transcript (Motley Fool)
Feb-27-25 05:32PM	Organogenesis: Q4 Earnings Snapshot (Associated Press Finance) -5.54%
04:05PM	Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results (GlobeNewswire)
Feb-26-25 08:09AM	What To Expect From Organogenesis Holdings Inc (ORGO) Q4 2024 Earnings (GuruFocus.com)
Jan-27-25 07:30AM	Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025 (GlobeNewswire) +5.06%
Nov-22-24 04:05PM	Organogenesis Expands Manufacturing Capacity to Support Future Growth (GlobeNewswire)
09:25AM	Loading…
Nov-15-24 09:25AM	Organogenesis Commends Final LCDs (GlobeNewswire)
Nov-13-24 02:23AM	Organogenesis Holdings Inc (ORGO) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com) +28.41%
Nov-12-24 09:45PM	Organogenesis (ORGO) Q3 2024 Earnings Call Transcript (Motley Fool)
05:40PM	Organogenesis (ORGO) Tops Q3 Earnings and Revenue Estimates (Zacks)
04:37PM	Organogenesis: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results (GlobeNewswire)
04:01PM	Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock (GlobeNewswire)
Nov-11-24 05:05PM	Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis (GlobeNewswire) +6.71%
Oct-16-24 07:30AM	Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024 (GlobeNewswire)
Oct-01-24 04:05PM	Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers (GlobeNewswire)
Sep-04-24 04:05PM	Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September (GlobeNewswire)
Aug-09-24 12:30AM	Organogenesis (ORGO) Q2 2024 Earnings Call Transcript (Motley Fool)
Aug-08-24 09:57PM	ORGO Stock Earnings: Organogenesis Hldgs Beats Revenue for Q2 2024 (InvestorPlace)
06:35PM	Organogenesis (ORGO) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:24PM	Organogenesis: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results (GlobeNewswire)
04:04PM	Organogenesis Shares ReNu Program Update (GlobeNewswire)
Jul-20-24 01:44AM	Organogenesis Holdings Inc. (ORGO): Is It Among the Best NASDAQ Penny Stocks to Invest In Now? (Insider Monkey)
Jul-15-24 04:05PM	Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024 (GlobeNewswire) +6.92%
Jun-06-24 04:05PM	Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference (GlobeNewswire)
May-10-24 03:09PM	Organogenesis Holdings Inc. Reports First Quarter 2024 Results: A Close Look at Financial ... (GuruFocus.com) +32.89%
12:07PM	Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:49AM	Q1 2024 Organogenesis Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
May-09-24 08:45PM	Organogenesis (ORGO) Q1 2024 Earnings Call Transcript (Motley Fool)
05:41PM	Organogenesis: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 07:00AM	Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis (GlobeNewswire)
Apr-16-24 07:30AM	Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024 (GlobeNewswire)
Apr-03-24 07:30AM	Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case (GlobeNewswire) +6.13%
Mar-02-24 08:39AM	Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 06:29PM	Why Organogenesis Holding Stock Plummeted by 18% Today (Motley Fool) -18.21%
Feb-29-24 05:45PM	Organogenesis (ORGO) Reports Break-Even Earnings for Q4 (Zacks)
04:50PM	Organogenesis: Q4 Earnings Snapshot (Associated Press Finance)
04:38PM	Organogenesis Holdings Inc (ORGO) Faces Revenue Decline in Q4 and FY 2023, Aims for Growth in 2024 (GuruFocus.com)
04:05PM	Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance (GlobeNewswire)
Feb-12-24 07:30AM	Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference (GlobeNewswire) +5.21%
Feb-08-24 04:05PM	Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024 (GlobeNewswire)
Jan-15-24 12:00PM	Are You Looking for a Top Momentum Pick? Why Organogenesis (ORGO) is a Great Choice (Zacks)
Dec-28-23 12:00PM	Organogenesis (ORGO) is a Great Momentum Stock: Should You Buy? (Zacks)
Dec-19-23 05:08AM	3 Biotech Stock Buys to Boost and Supercharge Portfolios (Entrepreneur: Stocks) +6.93%
Nov-11-23 09:30AM	Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 06:47AM	Q3 2023 Organogenesis Holdings Inc Earnings Call (Thomson Reuters StreetEvents) +11.17%
Nov-09-23 07:45PM	Organogenesis (ORGO) Q3 2023 Earnings Call Transcript (Motley Fool)
05:41PM	Organogenesis: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-30-23 09:32AM	12 Best Micro Cap Stocks To Invest In (Insider Monkey)
Oct-05-23 07:30AM	Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023 (GlobeNewswire)
Sep-28-23 11:44AM	Why Shares of Organogenesis Holdings Are Up Thursday (Motley Fool) +27.92%
09:15AM	Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS (GlobeNewswire)
Sep-06-23 04:05PM	Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference (GlobeNewswire)
Aug-10-23 11:54AM	Why Shares of Organogenesis Holdings Are Dropping Thursday (Motley Fool) -18.88%
06:17AM	Q2 2023 Organogenesis Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-09-23 08:30PM	Organogenesis (ORGO) Q2 2023 Earnings Call Transcript (Motley Fool) -8.38%
04:43PM	Organogenesis: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 Guidance (GlobeNewswire)
Jul-31-23 03:33PM	3 Penny Stocks That Wall Street Analysts Cant Get Enough Of (InvestorPlace)
Jul-10-23 07:30AM	Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023 (GlobeNewswire)
Jul-03-23 06:00AM	Bionomics Announces Key Leadership Updates to Drive U.S.-Focused Transformation and Next Stage of Strategic Growth (GlobeNewswire)
May-30-23 06:21AM	Investors in Organogenesis Holdings (NASDAQ:ORGO) have unfortunately lost 33% over the last year (Simply Wall St.)
May-24-23 03:02PM	Why Shares of Organogenesis Climbed Wednesday (Motley Fool) +15.99%
May-13-23 11:32AM	Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-11-23 02:33PM	Why Shares of Organogenesis Holdings Jumped Thursday (Motley Fool) +37.14%
03:30AM	Organogenesis (ORGO) Q1 2023 Earnings Call Transcript (Motley Fool)
May-10-23 04:28PM	Organogenesis: Q1 Earnings Snapshot (AP Finance) -5.41%
04:05PM	Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-29-23 09:58AM	Despite recent sales, Organogenesis Holdings Inc. (NASDAQ:ORGO) insiders still hold the largest share with a 37% interest (Simply Wall St.)
Apr-27-23 07:30AM	Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of Directors (GlobeNewswire)
Apr-10-23 07:30AM	Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023 (GlobeNewswire)
Apr-02-23 09:30AM	Declining Stock and Decent Financials: Is The Market Wrong About Organogenesis Holdings Inc. (NASDAQ:ORGO)? (Simply Wall St.)
Mar-27-23 08:00AM	Organogenesis Applauds Findings from the Office of Inspector General (GlobeNewswire)

Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
NUSSDORF GLENN H	Director	Nov 26 '25	Sale	5.29	187,957	994,293	2,765,591	Nov 26 06:24 PM
NUSSDORF GLENN H	Director	Nov 24 '25	Sale	5.34	100,000	534,000	2,965,591	Nov 26 06:24 PM
NUSSDORF GLENN H	Director	Nov 25 '25	Sale	5.30	12,043	63,828	2,953,548	Nov 26 06:24 PM
Glenn Nussdorf	Director	Nov 25 '25	Proposed Sale	5.40	200,000	1,080,000		Nov 25 04:56 PM
Glenn Nussdorf	Director	Nov 24 '25	Proposed Sale	5.34	100,000	534,379		Nov 24 03:44 PM
NUSSDORF GLENN H	Director	May 14 '25	Buy	3.09	251,001	775,041	251,001	Nov 03 05:25 PM
NUSSDORF GLENN H	Director	May 15 '25	Buy	2.99	107,494	320,999	358,495	Nov 03 05:25 PM
NUSSDORF GLENN H	Director	Jun 10 '25	Sale	3.56	18,620	66,256	335,719	Nov 03 05:25 PM
NUSSDORF GLENN H	Director	Jun 09 '25	Sale	3.50	4,156	14,547	354,339	Nov 03 05:25 PM
Grow Brian	Chief Commercial Officer	Aug 11 '25	Option Exercise	2.47	4,060	10,028	674,550	Aug 13 04:08 PM
Freedman Lori	Chief Admin. and Legal Officer	Jun 05 '25	Buy	2.91	142,379	413,625	837,437	Jun 06 05:44 PM
Freedman Lori	Chief Admin. and Legal Officer	Jun 04 '25	Buy	2.82	100,863	284,716	695,058	Jun 06 05:44 PM
Freedman Lori	Chief Admin. and Legal Officer	Jun 06 '25	Buy	2.99	9,022	26,949	846,459	Jun 06 05:44 PM
Driscoll Michael Joseph	Director	Mar 04 '25	Proposed Sale	5.08	25,000	127,000		Mar 17 05:14 PM
Driscoll Michael Joseph	Director	Mar 04 '25	Sale	5.10	25,000	127,535	166,879	Mar 06 09:08 PM
Gillheeney Gary S.	President and CEO	Dec 13 '24	Sale	3.36	55,615	186,866	3,044,779	Dec 16 08:03 PM
Gillheeney Gary S.	President and CEO	Dec 16 '24	Sale	3.49	5,585	19,492	3,039,194	Dec 16 08:03 PM
Gillheeney Gary S.	President and CEO	Dec 11 '24	Sale	3.64	157,448	573,111	3,143,753	Dec 12 08:08 PM
Gillheeney Gary S.	President and CEO	Dec 10 '24	Sale	3.64	58,525	213,031	3,301,201	Dec 12 08:08 PM
Gillheeney Gary S.	President and CEO	Dec 12 '24	Sale	3.55	43,359	153,924	3,100,394	Dec 12 08:08 PM
Gillheeney Gary S.	President and CEO	Dec 05 '24	Option Exercise	0.99	1,067,245	1,056,573	3,419,194	Dec 09 08:05 PM
Gillheeney Gary S.	President and CEO	Dec 09 '24	Sale	3.52	41,052	144,503	3,359,726	Dec 09 08:05 PM
Gillheeney Gary S.	President and CEO	Dec 06 '24	Sale	3.65	18,416	67,218	3,400,778	Dec 09 08:05 PM
Gillheeney Gary S.	Officer	Dec 06 '24	Proposed Sale	3.59	380,000	1,364,200		Dec 06 04:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Black Swan Sale

50% Off Elite

Organogenesis Holdings Inc

Upgrade your FINVIZ experience